Biotechnology

SNC-Lavalin's technologists design projects to make optimum use of material and personnel. Bio-safety precautions are integrated in the preliminary stages of a project, as are the decontamination of all air locks and equipment. Automation is used wherever possible to reduce the risk of cross contamination with support equipment.

Recent Projects

· Vaccine Facility Conversion for GSK Wavre, Belgium

· New Artificial Blood Facility for Hemosol, Canada

· New Production Facility for DSM Biologics, Canada

· Hemosol - Hemolink^TM Commercial Production Facility, Canada